Richmond Eye Associates Eye Health and Disorders Donald W. Lumpkin, O.D. David M. Bowman, M.D. D. Alan Chandler, M.D. Bryan M. Brooks, M.D. Barry E. Roper, M.D. David W. MacMillan, M.D. Malcolm Magovern, M.D. Harold A. Bernstein, M.D.


Eye Health
and
Eye Disorders

About Lasik

Eye Disorders

Eye News Articles

Vision Tests

Eye Anatomy

About Optics

Eye Links

Special Interest

The Eye and Health

Interactive Sections

Clinical Section

Major Sections On:

Cataract
Glaucoma
Macular Degen
Diabetes
Contact Lens
Drug Side Effects


Eye Symptom Pages:
(13 Categories)


Eye Disorder Pages:
(Over 70 Listed)

Richmond Eye Associates
                         Eye Health and Disorders


Introduction: Medical Disorders Causing Eye Problems

This page discusses a selection of medical disorders which are known to lead to a variety of eye problems. Links to other pages discussing medical conditions causing eye problems are provided as well. There are many medical disorders where eye complications are found as part of a larger symptom complex. In some cases, several different parts of the eye, orbit, or visual system can be affected by the condition, which is why they are discussed on this page rather than on a specific symptom category page.

One example is thyroid related ocular problems, which is discussed on the Double Vision page. This condition not only causes double vision due to eye muscle involvement, but also can cause dry eye problems, eyelid problems, and potential loss of vision. Since the eye muscle problems are relatively common with thyroid dysfunction, it is discussed on that page.

In some cases, a medical physician may request an eye examination to determine if the eyes are being affected by the medical condition. There are numerous conditions which potentially have eye complications, and only a few are discussed here.

This page is divided into a group of medical disorders which also can affect the eyes. The next section discusses other medical disorders discussed elsewhere that have ocular complications.

Read this important information before proceeding further:

These sections are not intended to replace the professional examination and diagnosis by a physician, and they are presented here purely for informational purposes. All possible diagnoses and treatment options are not covered, and the information discussed should not be taken as a recommendation to self-diagnose and self-treat a condition. A misdiagnosed or improperly treated eye condition can result in a permanent loss of vision, or a permanent loss of function of the eye or visual system. In the case of any eye problem, seek medical attention promptly. This can include emergency room treatment, as well as treatment by a medical physician or eyecare provider.

Conditions Discussed on this Page:

For eye anatomy explanations, go to ANATOMY

Cicatricial Pemphigoid

Cicatricial Pemphigoid (also known as ocular cicatricial pemphigoid, and benign mucous membrane pemphigoid) is a relatively rare chronic inflammatory disease mainly affecting mucous membranes, such as the conjunctiva and inside of the mouth. Sometimes the throat, esophagus, and other areas are affected as well. In 25% of cases, the skin itself is involved. Patients most commonly affected are females under the age of 60.

When the eyes are involved (75% of the time), the condition usually begins as a chronic conjunctivitis, followed by scarring of the conjunctiva. One, or more commonly both, eyes can be affected. Over time, this leads to bands of scar tissue connecting the surface of the eye to the inside of the eyelid (symblepharon), with a loss of the space between the eyelid and the eye (the conjuctival fornix). This can lead to inturning of the eyelid (entropion), and inturning of eyelashes (trichiasis) which can scratch the eye. The scarring of the conjunctiva can lead to a loss of mucous secreting cells which help to lubricate the eye, as well as closure of tear glands (lacrimal ducts). This leads to drying of the corneal and ocular surface, which potentially can cause symptoms of dry eye (gritty sensation, burning, light sensitivity, and loss of vision), as well as more severe corneal ulceration, scarring, and neovascularization (growth of blood vessels on the corneal surface). Blindness from these problems occurs in 25% to 33% of patients with the disorder. Other areas of the body can be involved as well, requiring care from dermatologists, gastroenterologists, and ENT specialists. A rheumatologist or internist may coordinate treatment of the patient.

The diagnosis of the disorder is usually based on clinical findings. However, biopsy of the conjunctiva, or other involved mucous membranes or skin, can give a definitive diagnosis 80% of the time. Immunopathologic techniques, such as direct immunofluorescence or direct immunoelecton microscopy can identify linear immune deposits at the level of the epithelial basement membrane of the examined tissue. Other disorders which can simulate ocular cicatricial pemphigoid include:

  • Acne rosacea

  • Drug induced pseudo-pemphigoid

  • Infectious disorders, such as fungal infections

  • Chemical burns

  • Sarcoidosis

  • Squamous cell carcinoma of the conjunctiva

  • Stevens-Johnson syndrome

  • Trachoma

  • Epidermal bullosa

  • Atopic keratoconjunctivitis

The disorder requires systemic treatment (oral medication) rather than simply local treatment to the eye. Immunosuppressive agents, such as steroids and dapsone (a sulfa derivative), are used, but can have side effects. Dapsone has showed improvement in the ocular and oral condition in up to 88% of cases. Laboratory testing is required while dapsone is used to rule out hemolytic anemia. In more severe cases, cyclophosphamide, steroids, and azathioprine in combination can be used.

Supportive ocular care involves dealing with complications of the conjunctival scarring, and restoring the ocular surface lubrication. Preservative free lubricating ointments and drops need to be used frequently. Treatment of eyelid malpositions and inturning eyelashes can prevent corneal scarring. In some cases, corneal transplant may be necessary to restore corneal clarity, but the results are often disappointing even when the underlying disease can be controlled.

Return to Condition List

 

Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease of the muscles leading to weakness and easy fatigability. Commonly (80% to 90% of cases), the disorder presents itself with drooping upper eyelids (ptosis) and double vision. The symptoms are typically highly variable, intermittent, and may be asymmetrical between the two eyes. There may also be speech and swallowing difficulties, problems with facial expression, and weakness of the muscles of the arms and legs. The symptoms tend to improve after rest and in the morning, and tend to be worse later in the day and after exercise. The underlying problem is the development of antibodies to neuromuscular receptors present in all muscles (acetylcholine receptors). There is some relationship with the thymus gland, and there is a positive family history in about 5% of cases. Symptoms tend to appear in the middle age years for men and women. Some cases have occurred after bone marrow transplantation.

Patients with prominent ocular symptoms often develop a fairly severe drooping of one or both upper eyelids, worse when tired, that may interfere with vision. The double vision associated with myasthenia can be variable, and does not usually fit into a typical pattern of any one specific eye muscle being involved. Two recent tests that can be suggestive of myasthenia are the sleep test, and the ice pack test. In the sleep test, the degree of eyelid drooping and double vision lessens after the patient sleeps, or rests in a quiet, darkened room, for 30 minutes. In the ice pack test, the ice is placed over the droopy eyelid for 2 minutes. If the drooping lessens by 2 millimeters or more, myasthenia may be a cause. There are other office tests that can be performed to aid in diagnosis (Tensilon test).

Treatment of the disorder has typically been with drugs that block the enzyme that degrades the neurotransmitter acetylcholine at the neuromuscular junction. Thus, the neurotransmitter will stay in the junction longer, and is better able to stimulate the muscle to contract. However, these drugs seem to be less effective in reducing the ocular symptoms than those related to other parts of the body. Steroids and other immunosuppressants such as azathioprine have been successful in reducing ocular symptoms, and in slowing the worsening of the disease over time. These medications are not without side effects, and need to be closely monitored by the treating physician. In some cases, removal of the thymus gland may help the disorder.

Return to Condition List

 

Sarcoidosis

Sarcoidosis is an inflammatory disease of the body which commonly affects the eyes (25% to 50% of patients). It is more frequently seen in African-Americans at a rate of 10:1 compared to Caucasians. Females tend to be more commonly affected. Multiple systems throughout the body can show symptoms. Granulomas, or inflammatory nodules, develop in organs and throughout the body. They lungs are commonly affected (90% of cases), and pulmonary function may be reduced. Chest X-rays are commonly monitored in sarcoidosis, since nodules in and around the lungs can be visualized. Skin nodules can occur, as well as muscle aches, generalized fatigue, and low grade fever.

Less commonly, neurological and central nervous system involvement can occur, potentially affecting the visual system. An inflammatory neuropathy of the optic nerve of one or both eyes can lead to a loss of vision, or blind spots in the vision. Involvement of the brain itself can cause visual loss. Paralysis of the third cranial nerve has been reported, leading to double vision, as well as the facial nerve (seventh cranial nerve), leading to a paralysis of the facial muscles.

The most common ocular complication of sarcoid is inflammation within the eye, known as iritis or uveitis. In fact, sarcoidosis is one of the most common identifiable causes of uveitis in adults. Symptoms of uveitis can range from ocular redness, aching, and sensitivity to light, to blurred vision and floaters in the vision.

Eyelid nodules and orbital nodules can affect ocular movement, and in some cases, cause protrusion of the eye itself. If the tear gland (lacrimal gland) is involved, tear production may stop, and a significant dry eye problem can ensue. In some cases, nodules of the conjunctiva can occur. Biopsy of conjunctival or lacrimal gland nodules can be useful for diagnosis.

The cause of sarcoidosis is unknown. Diagnosis is by clinical findings as well as laboratory testing (elevation of the ACE level, or angiotensin converting enzyme level), chest X-ray, biopsy of nodules, and in some cases, Gallium scan of the head and neck. Treatment is by anti-inflammatory agents, most commonly steroids by mouth. Since the disorder tends to be chronically recurrent, the amount of steroid is titrated to the level of disease activity. In some cases, sarcoid has only a mild, self-limited course. In more severe cases, or in those affecting the central nervous system, stronger anti-inflammatory agents such as cyclophosphamide may be needed. Ocular steroids, usually in the form of eyedrops, can control inflammation, but may lead to complications of cataract and glaucoma.

Return to Condition List

 

Lyme Disease

Lyme disease is a multi-system disorder caused by an immune reaction to the spirochete Borelia burgdorferi transmitted by the Dear tick (Ixodes dammini). There are common ocular complications during all stages of Lyme disease. The disease is most common in the Northeast and upper Midwest United States. It involves joint pain and dermatological and ophthalmic findings, as well as neurologic and cardiac abnormalities. Three stages of Lyme disease have been described, which may overlap:
 

  • Stage 1: The earliest stage includes a flu-like illness with a typical expanding "bull's-eye" rash. This may or may not be associated with a known tick bite. Some patients can develop conjunctivitis during this stage.

  • Stage 2: The second stage of the disease (after weeks to months of the disease) includes cardiac involvement (8%) and neurologic involvement (15%). This can include meningitis and paralysis of cranial nerves. Paralysis of the third or sixth cranial nerves affect eye movement, and lead to double vision. Paralysis of the seventh cranial nerve causes Bell's palsy, or drooping of one side of the face. During this stage inflammatory ocular disorders such as iritis, retinal vasculitis, chorioretinitis, and optic disc edema can occur. These conditions can cause a loss of vision.

  • Stage 3: The last stage of the disease, starting within 2 weeks to 2 years of the infection, include arthritis and chronic neurologic syndromes. This includes fatigue syndromes and focal central nervous system disorders. Ocular findings in this stage include corneal inflammation (keratitis) and double vision.

Treatment of Lyme disease is by commonly available antibiotics. Longer treatment is required for cases with neurological involvement, and intravenous antibiotics are required for severe neurological involvement and arthritis.

Return to Condition List

 

Eye and Orbital Cancer

There are numerous malignancies that can affect virtually any part of the eye, eyelids, orbit, and optic nerve. Fortunately, these conditions are very rare. Due to the wide scope of information concerning ocular and orbital malignancies, I recommend the following site for further information on this subject: Eye Cancer.com. This site contains an excellent review of ocular, orbital, and eyelid malignancies, including photographs, case histories, and treatment options. The site is written by a prominent specialist in the field of ocular cancer.

Return to Condition List

 


 


Other Medical Conditions causing eye problems found on other pages


Footer

At Richmond Eye Associates, "We Specialize in Family Eye Care"
Call 804-270-0330 for an Appointment
Toll Free 1-800-707-0330
find us on facebook

Request an Appointment Online  |  Check Here Before Your Appointment | Locations
About Richmond Eye Associates | Specialties |  Insurances Accepted
Laser Vision Correction | Optical Shops  
Eye Disorder Section | Eye News Articles | Eye Health Issues | Special Interest Sections
Contact Richmond Eye Associates | Links | Interactive Sections
Career Opportunities | Public Service Programs | Clinical Section
Home Page | Terms of Use and Copyright
| Notice of Privacy Practices


Barry E. Roper, M.D.    D. Alan Chandler, M.D.    Malcolm Magovern, M.D.    Harold A. Bernstein, M.D.
David M. Bowman, M.D.     Bryan M. Brooks, M.D.     Donald W. Lumpkin, O.D.